Multicenter double-blind randomized phase II: FOLFOX + ziv-aflibercept/placebo for patients (pts) with chemo-naive metastatic esophagogastric adenocarcinoma (MEGA).
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Peter C. Enzinger, Nadine Jackson McCleary, Hui Zheng, Thomas Adam Abrams, Matthew B. Yurgelun, Christopher G. Azzoli, James M. Cleary, Douglas Adam Rubinson, Gabriel Brooks, Jennifer A. Chan, Lipika Goyal, Jeffrey A. Meyerhardt, Kimmie Ng, Deborah Schrag, Diane M. F. Savarese, Christopher Graham, Margaret M. Carey, Charles S. Fuchs
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2589474057